CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS

  • RBQM Adoption: Current Use, Overcoming Barriers, And Anticipating ICH E6 (R3)

    Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts survey contributor, discusses the findings of the groups’ joint global research study with CluePoints and Price Waterhouse Cooper (PwC), the implications of the upcoming ICH E6(R3) guidelines, and the future of risk-based clinical trial conduct. 

  • How To Accelerate Digital Clinical Transformation Through A Holistic Approach

    Only one third of companies that have started a digital transformation journey has witnessed the expected ROI/revenue benefits. In the successful cases, a holistic, integrated approach created the transformational value. Explore the 10 key enterprise capabilities for successful digital clinical transformation.

IRT RESOURCES

RBQM RESOURCES

RTSM RESOURCES